ID   CAH14_HUMAN             Reviewed;         337 AA.
AC   Q9ULX7; Q5TB24; Q8NCF4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Carbonic anhydrase 14;
DE            EC=4.2.1.1;
DE   AltName: Full=Carbonate dehydratase XIV;
DE   AltName: Full=Carbonic anhydrase XIV;
DE            Short=CA-XIV;
DE   Flags: Precursor;
GN   Name=CA14; ORFNames=UNQ690/PRO1335;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10512682; DOI=10.1006/geno.1999.5938;
RA   Fujikawa-Adachi K., Nishimori I., Taguchi T., Onishi S.;
RT   "Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression,
RT   and mapping to chromosome 1.";
RL   Genomics 61:74-81(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=16807956; DOI=10.1002/chem.200600159;
RA   Temperini C., Scozzafava A., Vullo D., Supuran C.T.;
RT   "Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA,
RT   VII, and XIV with l- and d-histidine and crystallographic analysis of
RT   their adducts with isoform II: engineering proton-transfer processes
RT   within the active site of an enzyme.";
RL   Chemistry 12:7057-7066(2006).
RN   [8]
RP   ENZYME REGULATION.
RX   PubMed=16686544; DOI=10.1021/jm0603320;
RA   Temperini C., Scozzafava A., Vullo D., Supuran C.T.;
RT   "Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA,
RT   VII, and XIV with L- and D-phenylalanine and crystallographic analysis
RT   of their adducts with isozyme II: stereospecific recognition within
RT   the active site of an enzyme and its consequences for the drug
RT   design.";
RL   J. Med. Chem. 49:3019-3027(2006).
RN   [9]
RP   ENZYME REGULATION.
RX   PubMed=17705204; DOI=10.1002/anie.200701189;
RA   Koehler K., Hillebrecht A., Schulze Wischeler J., Innocenti A.,
RA   Heine A., Supuran C.T., Klebe G.;
RT   "Saccharin inhibits carbonic anhydrases: possible explanation for its
RT   unpleasant metallic aftertaste.";
RL   Angew. Chem. Int. Ed. Engl. 46:7697-7699(2007).
RN   [10]
RP   ENZYME REGULATION.
RX   PubMed=17127057; DOI=10.1016/j.bmcl.2006.11.027;
RA   Temperini C., Innocenti A., Scozzafava A., Mastrolorenzo A.,
RA   Supuran C.T.;
RT   "Carbonic anhydrase activators: L-Adrenaline plugs the active site
RT   entrance of isozyme II, activating better isoforms I, IV, VA, VII, and
RT   XIV.";
RL   Bioorg. Med. Chem. Lett. 17:628-635(2007).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=17314045; DOI=10.1016/j.bmcl.2007.01.113;
RA   Temperini C., Innocenti A., Guerri A., Scozzafava A., Rusconi S.,
RA   Supuran C.T.;
RT   "Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-
RT   ray crystal structure of the antiviral drug foscarnet complexed to
RT   human carbonic anhydrase I.";
RL   Bioorg. Med. Chem. Lett. 17:2210-2215(2007).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=19186056; DOI=10.1016/j.bmcl.2009.01.038;
RA   Crocetti L., Maresca A., Temperini C., Hall R.A., Scozzafava A.,
RA   Muehlschlegel F.A., Supuran C.T.;
RT   "A thiabendazole sulfonamide shows potent inhibitory activity against
RT   mammalian and nematode alpha-carbonic anhydrases.";
RL   Bioorg. Med. Chem. Lett. 19:1371-1375(2009).
RN   [13]
RP   ENZYME REGULATION.
RX   PubMed=19206230; DOI=10.1021/ja809683v;
RA   Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.-A.,
RA   Scozzafava A., Quinn R.J., Supuran C.T.;
RT   "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a
RT   new class of suicide inhibitors.";
RL   J. Am. Chem. Soc. 131:3057-3062(2009).
RN   [14]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RX   PubMed=18618712; DOI=10.1002/prot.22144;
RA   Di Fiore A., Monti S.M., Hilvo M., Parkkila S., Romano V., Scaloni A.,
RA   Pedone C., Scozzafava A., Supuran C.T., De Simone G.;
RT   "Crystal structure of human carbonic anhydrase XIII and its complex
RT   with the inhibitor acetazolamide.";
RL   Proteins 74:164-175(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-325, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 16-290, ZINC-BINDING SITES,
RP   GLYCOSYLATION AT ASN-213, AND DISULFIDE BOND.
RX   PubMed=24374484; DOI=10.1002/bip.22456;
RA   Alterio V., Pan P., Parkkila S., Buonanno M., Supuran C.T.,
RA   Monti S.M., De Simone G.;
RT   "The structural comparison between membrane-associated human carbonic
RT   anhydrases provides insights into drug design of selective
RT   inhibitors.";
RL   Biopolymers 101:769-778(2014).
CC   -!- FUNCTION: Reversible hydration of carbon dioxide.
CC   -!- CATALYTIC ACTIVITY: H(2)CO(3) = CO(2) + H(2)O.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:24374484};
CC   -!- ENZYME REGULATION: Activated by histamine, L-adrenaline, L- and D-
CC       histidine, and L- and D-phenylalanine. Inhibited by coumarins,
CC       saccharin, sulfonamide derivatives such as acetazolamide (AZA) and
CC       Foscarnet (phosphonoformate trisodium salt).
CC       {ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16807956,
CC       ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17314045,
CC       ECO:0000269|PubMed:17705204, ECO:0000269|PubMed:18618712,
CC       ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=7.9 mM for CO(2) {ECO:0000269|PubMed:18618712};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: High expression in all parts of the central
CC       nervous system and lower expression in adult liver, heart, small
CC       intestine, colon, kidney, urinary bladder and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the alpha-carbonic anhydrase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB025904; BAA85002.1; -; mRNA.
DR   EMBL; AY358689; AAQ89052.1; -; mRNA.
DR   EMBL; AK074765; BAC11191.1; -; mRNA.
DR   EMBL; BT020054; AAV38857.1; -; mRNA.
DR   EMBL; AL138795; CAI22810.1; -; Genomic_DNA.
DR   EMBL; BC034412; AAH34412.1; -; mRNA.
DR   CCDS; CCDS947.1; -.
DR   RefSeq; NP_036245.1; NM_012113.2.
DR   UniGene; Hs.528988; -.
DR   PDB; 4LU3; X-ray; 2.00 A; A=16-290.
DR   PDB; 5CJF; X-ray; 1.83 A; A=16-291.
DR   PDBsum; 4LU3; -.
DR   PDBsum; 5CJF; -.
DR   ProteinModelPortal; Q9ULX7; -.
DR   SMR; Q9ULX7; -.
DR   BioGrid; 117162; 47.
DR   IntAct; Q9ULX7; 1.
DR   STRING; 9606.ENSP00000358107; -.
DR   BindingDB; Q9ULX7; -.
DR   ChEMBL; CHEMBL3510; -.
DR   DrugBank; DB00819; Acetazolamide.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00909; Zonisamide.
DR   GuidetoPHARMACOLOGY; 2598; -.
DR   iPTMnet; Q9ULX7; -.
DR   PhosphoSitePlus; Q9ULX7; -.
DR   BioMuta; CA14; -.
DR   DMDM; 8928036; -.
DR   EPD; Q9ULX7; -.
DR   PaxDb; Q9ULX7; -.
DR   PeptideAtlas; Q9ULX7; -.
DR   PRIDE; Q9ULX7; -.
DR   DNASU; 23632; -.
DR   Ensembl; ENST00000369111; ENSP00000358107; ENSG00000118298.
DR   GeneID; 23632; -.
DR   KEGG; hsa:23632; -.
DR   UCSC; uc001etx.5; human.
DR   CTD; 23632; -.
DR   DisGeNET; 23632; -.
DR   GeneCards; CA14; -.
DR   HGNC; HGNC:1372; CA14.
DR   HPA; HPA008482; -.
DR   MIM; 604832; gene.
DR   neXtProt; NX_Q9ULX7; -.
DR   OpenTargets; ENSG00000118298; -.
DR   PharmGKB; PA25988; -.
DR   eggNOG; KOG0382; Eukaryota.
DR   eggNOG; COG3338; LUCA.
DR   GeneTree; ENSGT00760000118915; -.
DR   HOGENOM; HOG000112637; -.
DR   HOVERGEN; HBG002837; -.
DR   InParanoid; Q9ULX7; -.
DR   KO; K01672; -.
DR   OMA; SYPECGS; -.
DR   OrthoDB; EOG091G0XFM; -.
DR   PhylomeDB; Q9ULX7; -.
DR   TreeFam; TF316425; -.
DR   BRENDA; 4.2.1.1; 2681.
DR   Reactome; R-HSA-1475029; Reversible hydration of carbon dioxide.
DR   SABIO-RK; Q9ULX7; -.
DR   ChiTaRS; CA14; human.
DR   GeneWiki; CA14; -.
DR   GenomeRNAi; 23632; -.
DR   PRO; PR:Q9ULX7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000118298; -.
DR   CleanEx; HS_CA14; -.
DR   ExpressionAtlas; Q9ULX7; baseline and differential.
DR   Genevisible; Q9ULX7; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004089; F:carbonate dehydratase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   Gene3D; 3.10.200.10; -; 1.
DR   InterPro; IPR001148; Carbonic_anhydrase_a.
DR   InterPro; IPR023561; Carbonic_anhydrase_a-class.
DR   InterPro; IPR018431; Carbonic_anhydrase_CA14.
DR   PANTHER; PTHR18952; PTHR18952; 1.
DR   PANTHER; PTHR18952:SF166; PTHR18952:SF166; 1.
DR   Pfam; PF00194; Carb_anhydrase; 1.
DR   SMART; SM01057; Carb_anhydrase; 1.
DR   SUPFAM; SSF51069; SSF51069; 1.
DR   PROSITE; PS51144; ALPHA_CA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein; Lyase;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix; Zinc.
FT   SIGNAL        1     15       {ECO:0000255}.
FT   CHAIN        16    337       Carbonic anhydrase 14.
FT                                /FTId=PRO_0000004251.
FT   TOPO_DOM     16    290       Extracellular. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TOPO_DOM    312    337       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       20    278       Alpha-carbonic anhydrase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01134}.
FT   REGION      217    218       Substrate binding.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE     84     84       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P00918}.
FT   ACT_SITE    144    144       {ECO:0000250|UniProtKB:P00918}.
FT   METAL       109    109       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:24374484}.
FT   METAL       111    111       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:24374484}.
FT   METAL       135    135       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:24374484}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:24374484}.
FT   DISULFID     40    221       {ECO:0000269|PubMed:24374484}.
FT   CONFLICT    229    229       V -> A (in Ref. 3; BAC11191).
FT                                {ECO:0000305}.
FT   STRAND       24     26       {ECO:0000244|PDB:5CJF}.
FT   HELIX        30     32       {ECO:0000244|PDB:5CJF}.
FT   HELIX        33     36       {ECO:0000244|PDB:5CJF}.
FT   HELIX        38     41       {ECO:0000244|PDB:5CJF}.
FT   STRAND       42     44       {ECO:0000244|PDB:5CJF}.
FT   HELIX        52     54       {ECO:0000244|PDB:5CJF}.
FT   STRAND       66     68       {ECO:0000244|PDB:5CJF}.
FT   STRAND       77     81       {ECO:0000244|PDB:5CJF}.
FT   STRAND       86     89       {ECO:0000244|PDB:5CJF}.
FT   STRAND       95    101       {ECO:0000244|PDB:5CJF}.
FT   STRAND      103    112       {ECO:0000244|PDB:5CJF}.
FT   STRAND      122    125       {ECO:0000244|PDB:5CJF}.
FT   STRAND      131    140       {ECO:0000244|PDB:5CJF}.
FT   TURN        141    143       {ECO:0000244|PDB:5CJF}.
FT   HELIX       147    150       {ECO:0000244|PDB:5CJF}.
FT   STRAND      157    169       {ECO:0000244|PDB:5CJF}.
FT   HELIX       172    178       {ECO:0000244|PDB:5CJF}.
FT   HELIX       179    183       {ECO:0000244|PDB:5CJF}.
FT   STRAND      190    193       {ECO:0000244|PDB:5CJF}.
FT   HELIX       198    201       {ECO:0000244|PDB:5CJF}.
FT   STRAND      209    214       {ECO:0000244|PDB:5CJF}.
FT   STRAND      225    232       {ECO:0000244|PDB:5CJF}.
FT   STRAND      234    237       {ECO:0000244|PDB:5CJF}.
FT   HELIX       238    245       {ECO:0000244|PDB:5CJF}.
FT   STRAND      249    255       {ECO:0000244|PDB:5CJF}.
FT   STRAND      275    277       {ECO:0000244|PDB:5CJF}.
SQ   SEQUENCE   337 AA;  37668 MW;  6E101C44EA70A700 CRC64;
     MLFSALLLEV IWILAADGGQ HWTYEGPHGQ DHWPASYPEC GNNAQSPIDI QTDSVTFDPD
     LPALQPHGYD QPGTEPLDLH NNGHTVQLSL PSTLYLGGLP RKYVAAQLHL HWGQKGSPGG
     SEHQINSEAT FAELHIVHYD SDSYDSLSEA AERPQGLAVL GILIEVGETK NIAYEHILSH
     LHEVRHKDQK TSVPPFNLRE LLPKQLGQYF RYNGSLTTPP CYQSVLWTVF YRRSQISMEQ
     LEKLQGTLFS TEEEPSKLLV QNYRALQPLN QRMVFASFIQ AGSSYTTGEM LSLGVGILVG
     CLCLLLAVYF IARKIRKKRL ENRKSVVFTS AQATTEA
//
